These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15273767)

  • 21. Enhancing natural killer cells is beneficial in multiple sclerosis - No.
    Liu Q; Shi FD
    Mult Scler; 2019 Apr; 25(4):512-513. PubMed ID: 30421642
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancing natural killer cells is beneficial in multiple sclerosis - Yes.
    Laroni A
    Mult Scler; 2019 Apr; 25(4):510-512. PubMed ID: 30421641
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
    Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
    Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Change in the activity of natural killer cells in normal subjects and in virus diseases on exposure to interferon in vitro].
    Petrov RV; Saidov MZ; Koval'chuk LV; Sorokin AM; Kaganov BS
    Biull Eksp Biol Med; 1984 Apr; 97(4):438-40. PubMed ID: 6722306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis.
    Abb J; Deinhardt F; Zander H; Tenser RB; Rapp F; Goust JM; Fudenberg HH; Vilcek J; Ho M; Merigan TC; Oldstone MB; Jackson GG
    J Infect Dis; 1982 Jul; 146(1):109-15. PubMed ID: 6177805
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of adherent cells in supporting natural cytotoxicity reactions].
    Sorokin AM; Chenëv SB; Koval'chuk LV
    Biull Eksp Biol Med; 1989 Sep; 108(9):322-5. PubMed ID: 2611391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoferon (AM3) enhances the activities of early-type interferon inducers and natural killer cells.
    Moya P; Baixeras E; Barasoain I; Rojo JM; Ronda E; Alonso ML; Portolés A
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):243-56. PubMed ID: 2449486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha.
    Einhorn S; Ahre A; Blomgren H; Johansson B; Mellstedt H; Strander H
    Int J Cancer; 1982 Aug; 30(2):167-72. PubMed ID: 6182111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-interferon antibody inhibits natural killer cell activity in HSV-2 genital infection in C57BL/6J mice.
    Wrzos H; Abt PL; Rapp F
    Intervirology; 1990; 31(2-4):230-40. PubMed ID: 1695621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients.
    Neighbour PA
    Ann N Y Acad Sci; 1984; 436():181-91. PubMed ID: 6085226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
    Reiter Z
    J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of genital herpes with interferon].
    Danilow LN
    Zentralbl Gynakol; 1984; 106(5):331-3. PubMed ID: 6202080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity to herpes simplex virus: virus reactivation modulates lymphokine activity.
    Sheridan JF; Beck M; Aurelian L; Radowsky M
    J Infect Dis; 1985 Sep; 152(3):449-56. PubMed ID: 2411825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Circulating serum interferon and its effect on human natural killer cell activity].
    Cheknev SB; Ashmanova IaG; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Dec; 118(12):619-22. PubMed ID: 7535580
    [No Abstract]   [Full Text] [Related]  

  • 35. Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease.
    Merrill J; Jondal M; Seeley J; Ullberg M; Sidén A
    Clin Exp Immunol; 1982 Feb; 47(2):419-30. PubMed ID: 6176377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of mouse NK cells by interferon.
    Senik A; Gresser I; Maury C; Gidlund M; Orn A; Wigzell H
    Transplant Proc; 1979 Mar; 11(1):993-6. PubMed ID: 452109
    [No Abstract]   [Full Text] [Related]  

  • 37. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
    Mandler RN; Biddison WE; Mandler R; Serrate SA
    J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of natural killer cells in two random-bred strains of athymic rats by interferon-inducing pyrimidinone.
    Lotzová E; Savary CA; Khan A; Stringfellow DA
    J Immunol; 1984 May; 132(5):2566-70. PubMed ID: 6201549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.
    Kastrukoff LF; Morgan NG; Zecchini D; White R; Petkau AJ; Satoh J; Paty DW
    Neurology; 1999 Jan; 52(2):351-9. PubMed ID: 9932956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interferon and natural cytotoxicity].
    Skurska Z
    Postepy Hig Med Dosw; 1984; 38(5-6):615-32. PubMed ID: 6085589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.